scispace - formally typeset
Open AccessJournal ArticleDOI

RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications

TLDR
The underlying mechanisms of m6A modifications in tumorigenesis are emphasized and the potential m 6A regulators-associated therapeutic targets for tumor therapy are introduced.
Abstract
N6-Methyladenosine (m6A) RNA modification brings a new dawn for RNA modification researches in recent years. This posttranscriptional RNA modification is dynamic and reversible, and is regulated by methylases ("writers"), demethylases ("erasers"), and proteins that preferentially recognize m6A modifications ("readers"). The change of RNA m6A modification regulates RNA metabolism in eucaryon, including translation, splicing, exporting, decay, and processing. Thereby the dysregulation of m6A may lead to tumorigenesis and progression. Given the tumorigenic role of abnormal m6A expression, m6A regulators may function as potential clinical therapeutic targets for cancers. In this review, we emphasize on the underlying mechanisms of m6A modifications in tumorigenesis and further introduce the potential m6A regulators-associated therapeutic targets for tumor therapy.

read more

Citations
More filters
Journal ArticleDOI

m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer

TL;DR: Wang et al. as mentioned in this paper analyzed the gene expression data of 24 major m6A RNA methylation regulators from 775 patients with esophageal cancer from TCGA dataset.
Journal ArticleDOI

N6-methyladenosine RNA modification regulates strawberry fruit ripening in an ABA-dependent manner.

TL;DR: In this paper, the authors show that m6A methylation displays a dramatic change at ripening onset of strawberry, a classical non-climacteric fruit, and demonstrate that the methyltransferases MTA and MTB are indispensable for normal ripening of strawberry.
Journal ArticleDOI

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.

TL;DR: The molecular mechanisms underlying resistance to third-generation EGFR inhibitors and the ongoing efforts to address and overcome this chemoresistance are summarized.
Journal ArticleDOI

RNA methylation and cancer treatment.

TL;DR: In this paper, the relationship between different types of RNA methylation and cancer, and some FTO inhibitors in cancer treatment is discussed, and a review outlines the relationship among different types and cancer cell proliferation, cellular stress, metastasis, immune response.
References
More filters
Journal ArticleDOI

Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3′ UTRs and near Stop Codons

TL;DR: A method is presented for transcriptome-wide m(6)A localization, which combines m( 6)A-specific methylated RNA immunoprecipitation with next-generation sequencing (MeRIP-Seq) and reveals insights into the epigenetic regulation of the mammalian transcriptome.
Journal ArticleDOI

N6-methyladenosine-dependent regulation of messenger RNA stability

TL;DR: It is shown that m6A is selectively recognized by the human YTH domain family 2 (YTHDF2) ‘reader’ protein to regulate mRNA degradation and established the role of YTH DF2 in RNA metabolism, showing that binding of Y THDF2 results in the localization of bound mRNA from the translatable pool to mRNA decay sites, such as processing bodies.
Journal ArticleDOI

N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO.

TL;DR: FTO exhibits efficient oxidative demethylation activity of abundant N6-methyladenosine (m6A) residues in RNA in vitro, and it is shown that FTO partially colocalizes with nuclear speckles, supporting m6A in nuclear RNA as a physiological substrate of FTO.
Related Papers (5)